Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Cost of Revenue
$1.25B
TTM · Period ending: · USD
BIO Cost of Revenue
Latest reported$1.25Bperiod ending
Latest reported$1.25Bperiod ending
BIO TTM Cost of Revenue ($0.00 → $1.25B)
TTM cost of revenue
High-resolution chart · PNG
BIO cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 314,496,000 | |
| 305,039,000 | |
| 300,055,000 | |
| 311,873,000 | |
| 284,587,000 | |
| 253,432,000 | |
| 227,700,000 | |
| 191,700,000 | |
| 185,900,000 | |
| 184,800,000 | |
| 181,500,000 | |
| 178,800,000 | |
| 179,100,000 | |
| 177,400,000 | |
| 169,900,000 | |
| 169,300,000 | |
| 165,100,000 | |
| 160,700,000 | |
| 164,000,000 | |
| 161,300,000 | |
| 160,900,000 | |
| 160,400,000 | |
| 155,200,000 | |
| 150,100,000 | |
| 146,200,000 | |
| 141,500,000 | |
| 139,000,000 | |
| 137,800,000 | |
| 138,400,000 | |
| 138,600,000 | |
| 134,300,000 | |
| 131,100,000 | |
| 128,500,000 | |
| 124,900,000 | |
| 124,600,000 | |
| 123,000,000 | |
| 122,000,000 | |
| 123,600,000 | |
| 122,100,000 | |
| 121,500,000 | |
| 120,700,000 | |
| 115,800,000 | |
| 113,300,000 | |
| 107,700,000 | |
| 101,300,000 | |
| 100,000,000 | |
| 73,500,000 | |
| 46,500,000 | |
| 24,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |